ANDA 210294, held by Am Regent. Isosulfan Blue.
As of Nov 16, 2026, ANDA 210294 (Isosulfan Blue), held by Am Regent, was first approved by FDA on May 17, 2023, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 17, 2023 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Isosulfan Blue50MG/5ML (10MG/ML) ยท solution;subcutaneous | Isosulfan Blue | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters